$30.81▼-0.95 (-2.99%)
Extended:$30.81+0.00 (+0.00%)
Alamar Biosciences, Inc. (ALMR)
R&D to Revenue
50.49%
Fiscal year · Period ending:

ALMR R&D to Revenue
Latest reported50.49%period ending
Latest reported50.49%period ending
ALMR FY R&D/Revenue (0.00% → 50.49%)
Latest values, visible window
High-resolution chart · PNG
What is r&d to revenue?
R&D spending as percentage of revenue.
ALMR r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 50.4925% | |
| 0% |
Explore More
ALMR Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance